This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
12.6 Literatur
Allgaier HP, Becker G, Blum HE. Therapiestudie des hepatozellulären Karzinoms (HECTOR). Deutsche Medizinische Wochenschrift 2000; 125: 320.
Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society A 1969; 132: 235–244.
Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50:1029–1041.
Califf RM, Lee KJ (eds.). Data and safety monitoring committees: philosophy and practice. American Heart Journal 2001; 141: Part 1: 154–163, Part 2: 289–305, Part 3: 536–549.
Coronary Drug Project Research Group. Practical aspects of decision making in clinical trials: the Coronary Drug Project as a case study. Controlled Clinical Trials 1980; 1:363–376.
DeMets DL, Hardy R, Friedman L, Lan G. Statistical aspects of early termination in the Beta-Blocker Heart Attack Trial. Controlled Clinical Trials 1984; 5: 362–372.
DeMets DL, Pocock SJ, Julian DG. The agonizing negative trend in monitoring of clinical trials. Lancet 1999; 354: 1983–1988.
DeMets DL, Furberg CD, Friedman L (eds). Data monitoring in clinical trials: a case studies approach. New York: Springer, 2005.
EMEA/ CHMP. Guideline on Data Monitoring Committees. London, UK: Committee for Medicinal Products for Human Use. Adoption by the CHMP July 2005. CHMP/EWP/5872/03Corr (Statistics in Medicine 2006;25:1639–1645).
EMEA/ CHMP. Reflection paper on methodological issues in confirmatory clinical trials with flexible design and analysis plan. London, UK: Committee for Medicinal Products for Human Use. Draft March 2006. CHMP/EWP/2459/02.
Emerson SS, Fleming TR. Interim analyses in clinical trials. Oncology 1990; 4: 126–133; discussion 134,136.
Ellenberg S, Fleming TR, DeMets DL. Data Monitoring Committees in clinical trials: a practical perspective. Chichester: Wiley, 2002.
Fleming TR, DeMets D. Monitoring of clinical trials: issues and recommendations. Controlled Clinical Trials 1993; 14: 183–197.
Hallstrom A, McBride R, Moore R. Toward vital status sweeps: a case history in sequential monitoring. Statistics in Medicine 1995; 14: 1927–1931.
Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. British Journal of Radiology 1971; 44: 793–797.
Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Boca Raton: Chapman und Hall/CRC, 2000.
Köpcke W. Zwischenauswertungen und vorzeitiger Abbruch von Therapiestudien: gemischte Strategien bei gruppensequentiellen Methoden und Verfahrensvergleiche bei Lebensdauerverteilungen. Berlin: Springer, 1984.
Lan KKG, DeMets D. Discrete sequential boundaries for clinical trials. Biometrika 1983;70: 650–663.
Lan KKG, DeMets D. Changing frequency of interim analysis in sequential monitoring. Biometrics 1989; 45: 1017–1020.
Lan KKG, Simon R, Halperin M. Stochastically curtailed tests in long-term clinical trials. Commmunications in Statistics 1982; C1: 207–219.
Lan KKG, Wittes J. The B-value: a tool for monitoring data. Biometrics 1988; 44: 579–585.
Lehmacher W, Wassmer G. Adaptive sample size calculation in group sequential trials. Biometrics 1999; 55:1286–1290.
Müller HH, Schäfer H. A general statistical principle for changing a design any time during the course of a trial. Statistics in Medicine 2004; 23: 2497–2508.
O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35: 549–556.
Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64: 191–199.
Skovlund E. Repeated significance tests on accumulating survival data. Journal of Clinical Epidemiology 1999; 52: 1083–1088.
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The early termination of clinical trials: causes, consequences, and control with special reference to trials in the field of arrhythmias and sudden death. Circulation 1994; 89:2892–2907.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Olschewski, M. (2007). Zwischenauswertungen und statistisches Monitoring der Ergebnisse von klinischen Studien. In: Methodik klinischer Studien. Statistik und ihre Anwendungen. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-36990-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-540-36990-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-36989-9
Online ISBN: 978-3-540-36990-5
eBook Packages: Life Science and Basic Disciplines (German Language)